Das könnte nicht die Zukunft sein, das IST die Zukunft. Bin mit Felsen investiert!
In den USA ist dieses Unternehmen ein Hype! Und wenn man einformiet ist, dann weiß man, dass dieses Unternehmen ein reiner Talismann ist. Man darf nicht außer Acht lassen, dass PositiveID neben dem Militär auch die Medizin technologisch revolutioniert. Der Gluco-Chip beispielsweise, welcher eigenständig den Insulin-Spiegel reguliert, das Messverfahren, den Blutzuckerspiegel am Atem zu erkennen. Biotech ist demnach auch kein kleines Wort, sondern eine kleine Revolution.
NOCH Penny, morgen ganz großer Dollar!
DELRAY BEACH, Fla., May 27, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today provided an update to stockholders on its 2014 progress. Year to date, the Company has achieved several key goals through the signing of agreements with large commercial and federal government organizations, including revenue generation.
In March, PositiveID entered into a contract with a large commercial partner to support a U.S. Department of Defense ("DoD") contract. The program will test and evaluate PositiveID's M-BAND (Microfluidics-based Bio-agent Autonomous Networked Detector) airborne bio-threat detector to provide the "best of breed" and most affordable options to protect the U.S. military. The Company expects to generate revenue of $841,000 from this contract during 2014.
The Company also announced one of its teaming partners was awarded a prime contract by the U.S. Defense Threat Reduction Agency to conduct research and development to combat weapons of mass destruction. The multiple-award indefinite delivery/indefinite quantity contract has a total value of up to $4 billion for all awardees, if all options are exercised. PositiveID will offer both its Firefly Dx handheld diagnostic system ("Firefly") as well as its M-BAND airborne bio-threat detector as part of the teaming agreement.
Most recently, the Company signed a Space Act Agreement with NASA'sAmes Research Center. Under this Space Act Agreement, NASA will assess the Company's Firefly technology for potential ground and space applications, while PositiveID will assess the technology to improve its development of the Firefly hardware for extreme environments, such as DoD field applications.
The Company has also strengthened its management team this year with the appointment of Lyle L. Probst as the Company's president, and the addition of U.S. homeland security and counter-terrorism expert Thomas DiNanno and businessman Michael Campbell to its advisory board.
"We set out at the beginning of this year with the objective of entering into strategic agreements and contracts with multiple government and commercial partners to further product development and commence revenue generation," stated William J. Caragol, PositiveID's Chairman and CEO. "We are proud of the goals we have achieved especially our intermediate goal of revenue generation. We look forward to building on our recent success and continuing to grow our revenue backlog."
Caragol continued, "We believe we have lined up strong partners to bring our products to market, and we are currently preparing M-BAND units for testing and evaluation by DoD. Working with our customer and our operating partners, we have fully developed the M-BAND system which we believe will drastically shorten the detection time and operating costs of the current BioWatch system."
Mr. Caragol will be presenting at the Third Annual Marcum MicroCap Conference on Thursday, May 29, 2014 at 3:30 pm ET at the Grand Hyatt Hotel in New York City. To listen to a live webcast of his presentation, please go to wsw.com/webcast/marcum2/psid.
Read more: www.nasdaq.com/press-release/...s-20140527-00436#ixzz33SLXgLwf